title: Tocilizumab and steroid boli for treatment-resistant anterior necrotizing scleritis.
authors.affiliation: Department of Ophthalmology, University Clinic Schleswig-Holstein, Campus Kiel, Kiel, Germany.
authors.forename: Jan
authors.initials: J
authors.lastname: Tode
authors.affiliation: Department of Rheumatology, University Clinic Schleswig-Holstein, Campus Kiel, Kiel, Germany.
authors.forename: Rainald
authors.initials: R
authors.lastname: Zeuner
authors.affiliation: Department of Ophthalmology, University Clinic Schleswig-Holstein, Campus Kiel, Kiel, Germany.
authors.forename: Mark
authors.initials: M
authors.lastname: Saeger
authors.affiliation: Department of Ophthalmology, University Clinic Schleswig-Holstein, Campus Kiel, Kiel, Germany.
authors.forename: Johann
authors.initials: J
authors.lastname: Roider
authors.affiliation: Department of Ophthalmology, University Clinic Schleswig-Holstein, Campus Kiel, Kiel, Germany.
authors.forename: Bernhard
authors.initials: B
authors.lastname: Nölle
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use*; D015423:Scleritis / Q000188:drug therapy* / Q000503:physiopathology; D014792:Visual Acuity / Q000187:drug effects
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011239:Prednisolone; C502936:tocilizumab